학술논문
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial
Document Type
Article
Author
Source
In: American Journal of Hematology . (American Journal of Hematology, 1 May 2021, 96(5):552-560)
Subject
Language
English
ISSN
10968652
03618609
03618609